KALV KalVista Pharmaceuticals, Inc. - Common Stock
$26,78
Prix · Mai 20, 2026
Données fondamentales au Mai 14, 2026
Fourchette 52 semaines
$10–$27
100% of range
Note des analystes
BUY
13 analysts
Objectif de cours
$29
+7% upside
P/E (TTM)
-3.7
ROE
-172.9%
Marge nette
—
KALV Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$26.78
Capitalisation Boursière
$685M
P/E (TTM)
-3.7
BPA (TTM)
$-3.69
Revenus (TTM)
$50M
Rendement div.
—
ROE
-172.9%
Dette/Capitaux propres
—
Fourchette 52 semaines
$10 – $27
KALV Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$50M
2018-04-30
→
2024-04-30
BPA
$-3.69
2020-04-30
→
2025-04-30
Flux de trésorerie libre
$-153M
2018-04-30
→
2025-04-30
Marges
—
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
KALV
Médiane des pairs
P/E (TTM)
-3.7
—
P/B
7.2
7.4
Price / FCF (Cours / FCF)
-4.5
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
KALV
Médiane des pairs
ROA
-67.2%
-47.6%
ROE
-172.9%
-62.8%
ROIC
-200.8%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
KALV
Médiane des pairs
Current Ratio (Ratio de liquidité)
5.4
5.6
Quick Ratio (Ratio de liquidité réduite)
2.9
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
KALV
Médiane des pairs
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
KALV
Médiane des pairs
KALV Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
13 analystes
- Achat fort 3 23,1%
- Achat 6 46,2%
- Conserver 4 30,8%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
5 analystes · 2026-05-15
Médiane
$27.00
Moyenne
$28.60
← En dessous de tous les objectifs
$26.78
Bas
$27.00
Haut
$35.00
Objectif médian
$27.00
+0,8%
Objectif moyen
$28.60
+6,8%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.23%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 31 mars 2026 | $-0.43 | $-0.48 | 0.05% |
| 31 décembre 2025 | $0.92 | $-0.48 | 1.4% |
| 31 mars 2025 | $-0.78 | $-0.89 | 0.11% |
| 31 décembre 2024 | $-0.91 | $-0.93 | 0.02% |
| 30 septembre 2024 | $-0.87 | $-0.93 | 0.06% |
| 30 juin 2024 | $-1.02 | $-0.75 | -0.27% |
Comparaison avec les pairs Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| KALV | $685M | -3.7 | — | — | -172.9% | — |
| RXRX | $2.16B | -2.8 | 26.9% | -863.4% | -62.9% | — |
| PGEN | $1.48B | -3.1 | 146.7% | -2588.2% | 3159.1% | — |
| NVAX | $1.09B | 2.6 | 64.7% | 39.2% | -977.1% | — |
| DMRA | — | — | 38.3% | -17981.1% | -167.0% | — |
| VIR | $841M | -1.9 | -7.6% | -638.9% | -51.1% | — |
| BCAX | $953M | -6.7 | — | — | -33.0% | — |
| BHVN | $1.50B | -1.6 | — | — | -310.8% | — |
| AVBP | $854M | -4.7 | — | — | -59.7% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 15
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | $50M | · | · | · | $13M | $16M | $8M | $2M | $2M | |
| R&D Expense | $72M | $86M | $80M | $70M | $41M | $40M | $35M | $18M | $13M | $15M | |
| SG&A Expense | $116M | $54M | $31M | $26M | $17M | $13M | $11M | $9M | $11M | $3M | |
| Operating Expenses | $188M | $140M | $111M | $97M | $58M | $53M | $46M | $27M | $24M | $17M | |
| Operating Income | $-188M | $-140M | $-111M | $-97M | $-58M | $-41M | $-30M | $-19M | $-22M | $-15M | |
| Interest Income | $6M | $4M | $2M | $1M | $903.0K | $2M | $1M | $82.0K | $36.0K | $50.0K | |
| Other Non-op | $5M | $10M | $16M | $15M | $10M | $10M | $8M | $4M | $2M | $2M | |
| Pretax Income | $-180M | $-127M | $-93M | $-82M | $-82M | $-29M | $-21M | $-16M | $-19M | $-11M | |
| Income Tax | $3M | $0 | $0 | $0 | $0 | $-124.0K | $124.0K | $0 | $0 | $0 | |
| Net Income | $-183M | $-127M | $-93M | $-82M | $-46M | $-29M | $-21M | $-16M | $-19M | $-11M | |
| EPS (Basic) | $-3.69 | $-3.44 | $-3.33 | $-3.36 | $-2.42 | $-1.64 | · | · | · | · | |
| EPS (Diluted) | $-3.69 | $-3.44 | $-3.33 | $-3.36 | $-2.42 | $-1.64 | · | · | · | · | |
| Shares (Basic) | 49,652,878 | 36,786,575 | 27,890,846 | 24,473,092 | 19,094,440 | 17,748,666 | · | · | · | · | |
| Shares (Diluted) | 49,652,878 | 36,786,575 | 27,890,846 | 24,473,092 | 19,094,440 | 17,748,666 | · | · | · | · | |
| EBITDA | $-187M | $-140M | $-110M | $-96M | $-57M | $-40M | $-29M | $-19M | $-22M | · |
Bilan 18
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $132M | $32M | $56M | $31M | $51M | $16M | $32M | $51M | $31M | $22M | |
| Prepaid Expense | $20M | $7M | $6M | $13M | $5M | $4M | $3M | $1M | $701.0K | $668.0K | |
| Current Assets | $242M | $226M | $172M | $194M | $264M | $89M | $116M | $59M | $34M | $25M | |
| PP&E (Net) | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $97.0K | $74.0K | |
| PP&E (Gross) | $7M | $6M | $6M | $5M | $4M | $3M | $3M | $2M | $410.0K | $418.0K | |
| Accum. Depreciation | $5M | $4M | $3M | $2M | $2M | $1M | $896.0K | $555.0K | $313.0K | $344.0K | |
| Other Non-current Assets | $2M | $567.0K | $106.0K | $193.0K | $200.0K | $178.0K | $173.0K | $173.0K | $50.0K | · | |
| Total Assets | $251M | $235M | $183M | $204M | $272M | $93M | $118M | $61M | $34M | $25M | |
| Accounts Payable | $5M | $9M | $5M | $4M | $2M | $2M | $3M | $1M | $1M | $1M | |
| Accrued Liabilities | $27M | $12M | $9M | $7M | $7M | $5M | $6M | $3M | $2M | $2M | |
| Current Liabilities | $45M | $23M | $15M | $12M | $10M | $8M | $18M | $23M | $3M | $3M | |
| Capital Leases | $4M | $6M | $7M | $7M | $5M | $1M | · | $58.0K | · | · | |
| Common Stock | $50.0K | $42.0K | $34.0K | $25.0K | $24.0K | $18.0K | $17.0K | $11.0K | $10.0K | · | |
| Retained Earnings | $-653M | $-470M | $-343M | $-250M | $-168M | $-122M | $-92M | $-72M | $-56M | $-37M | |
| AOCI | $-5M | $-3M | $-3M | $-4M | $-1M | $-2M | $-2M | $-1M | $-3M | $-75.0K | |
| Stockholders' Equity | $95M | $207M | $161M | $185M | $257M | $84M | $97M | $27M | $31M | $-37M | |
| Liabilities + Equity | $251M | $235M | $183M | $204M | $272M | $93M | $118M | $61M | $34M | $25M | |
| Shares Outstanding | 49,762,048 | 42,521,975 | 34,171,138 | 24,550,748 | 24,422,531 | 17,845,599 | 17,277,750 | 10,799,895 | 9,713,042 | 0 |
Flux de trésorerie 10
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $941.0K | $816.0K | $718.0K | $564.0K | $537.0K | $512.0K | $378.0K | $180.0K | $40.0K | $33.0K | |
| Other Non-cash | $30M | $37M | $17M | $4M | $16M | $-16M | $-16M | $26M | $-5M | · | |
| Operating Cash Flow | $-153M | $-89M | $-75M | $-78M | $-30M | $-45M | $-36M | $11M | $-24M | $-13M | |
| CapEx | $434.0K | $42.0K | $1M | $931.0K | $82.0K | $220.0K | $1M | $1M | $74.0K | $11.0K | |
| Investing Cash Flow | $91M | $-85M | $41M | $58M | $-148M | $17M | $-69M | $-1M | $34M | $-11.0K | |
| Stock Issued | $56M | $97M | $57M | · | $211M | $11M | $88M | $9M | $2.0K | $1.0K | |
| Net Stock Activity | $56M | $97M | $57M | · | $211M | $11M | $88M | $9M | $2.0K | · | |
| Financing Cash Flow | $160M | $151M | $58M | $2M | $212M | $12M | $88M | $9M | $2.0K | $33M | |
| Net Change in Cash | $100M | $-24M | $26M | $-20M | $35M | $-16M | $-19M | $20M | $9M | $19M | |
| Free Cash Flow | $-153M | $-89M | $-76M | $-79M | $-30M | $-45M | $-37M | $9M | $-24M | · |
Rentabilité 7
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -319.4% | -184.9% | -222.8% | · | · | |
| Net Margin | · | · | · | · | · | -229.4% | -129.1% | -188.3% | · | · | |
| Pretax Margin | · | · | · | · | · | -230.4% | -128.3% | -188.3% | · | · | |
| EBITDA Margin | · | · | · | · | · | -315.4% | -182.6% | -220.7% | · | · | |
| ROA | -67.2% | -60.5% | -48.0% | -34.6% | -25.4% | -27.6% | -23.2% | -33.0% | -63.0% | · | |
| ROE | -172.9% | -59.7% | -53.8% | -41.9% | -29.3% | -33.6% | -20.7% | -56.6% | 643.1% | · | |
| ROIC | -200.8% | -68.0% | -68.8% | -52.2% | -22.5% | -48.2% | -31.0% | -68.6% | · | · |
Liquidité et Solvabilité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.4 | 9.9 | 11.5 | 16.7 | 27.0 | 11.5 | 6.4 | 2.6 | 11.3 | · | |
| Quick Ratio | 2.9 | 1.4 | 3.7 | 2.7 | 5.2 | 2.0 | 1.8 | 2.2 | 10.3 | · |
Efficacité 1
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.1 | 0.2 | 0.2 | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $50M | $13M | $13M | $13M | $13M | $16M | $8M | $2M | · | |
| Net Income TTM | $-183M | $-127M | $-93M | $-82M | $-46M | $-29M | $-21M | $-16M | $-19M | · | |
| Market Cap | $685M | $483M | $291M | $313M | $610M | $195M | $397M | $104M | $73M | · | |
| P/E | -3.7 | -3.3 | -2.6 | -3.8 | -10.3 | -6.7 | · | · | · | · | |
| P/S | · | 9.7 | 23.0 | 24.6 | 48.1 | 15.3 | 24.6 | 12.4 | 48.4 | · | |
| P/B | 7.2 | 2.3 | 1.8 | 1.7 | 2.4 | 2.3 | 4.1 | 3.8 | 2.3 | · | |
| P / Tangible Book | 7.2 | 2.3 | 1.8 | 1.7 | 2.4 | 2.3 | · | · | · | · | |
| P / Cash Flow | -4.5 | -5.4 | -3.9 | -4.0 | -20.2 | -4.3 | -10.9 | 9.8 | -3.1 | · | |
| P / FCF | -4.5 | -5.4 | -3.8 | -4.0 | -20.2 | -4.3 | -10.6 | 11.4 | -3.1 | · | |
| Earnings Yield | -26.8% | -30.3% | -39.0% | -26.4% | -9.7% | -15.0% | · | · | · | · |
Compte de résultat 16
| Métrique | Tendance | Q1 2026 | Q3 2025 | Q1 2025 | Q4 2025 | Q1 2025 | Q3 2025 | Q2 2024 | Q3 2024 | Q1 2024 | Q4 2024 | Q3 2024 | Q2 2023 | Q1 2023 | Q4 2023 | Q3 2023 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | $14M | $1M | · | · | · | · | $0 | $0 | $50M | · | · | · | · | · | · | |
| Cost of Revenue | $3M | $1M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | $12M | $12M | $15M | $16M | $14M | $13M | $17M | $19M | $27M | $29M | $23M | $19M | $19M | $24M | $20M | $18M | |
| SG&A Expense | $49M | $47M | $45M | $23M | $36M | $30M | $29M | $25M | $18M | $9M | $11M | $11M | $10M | $8M | $7M | $8M | |
| Operating Expenses | $64M | $60M | $60M | $38M | $50M | $43M | $46M | $43M | $44M | $38M | $33M | $30M | $29M | $32M | $27M | $26M | |
| Operating Income | $-23M | $-46M | $-59M | $-52M | $-50M | $-43M | $-46M | $-43M | $-44M | $-38M | $-33M | $-30M | $-29M | $-32M | $-27M | $-26M | |
| Interest Income | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $617.0K | $684.0K | $776.0K | $923.0K | $809.0K | $732.0K | $449.0K | |
| Other Non-op | $3M | $2M | $818.0K | $-1M | $665.0K | $1M | $2M | $2M | $2M | $3M | $2M | $3M | $2M | $4M | $4M | $3M | |
| Pretax Income | $-23M | $-47M | $-58M | $-27M | $-48M | $-44M | · | $-39M | $-40M | $-4M | $-29M | · | · | · | · | · | |
| Income Tax | $0 | $2M | $2M | $-2M | $4M | $4M | · | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Income | $-23M | $-49M | $-60M | $-25M | $-52M | $-49M | $-42M | $-39M | $-40M | $-4M | $-29M | $-28M | $-25M | $-26M | $-21M | $-22M | |
| EPS (Basic) | $-0.43 | $-0.92 | $-1.12 | $-0.99 | $-0.98 | $-0.92 | $-0.91 | $-0.84 | $-0.87 | $-1.06 | $-0.84 | $-0.80 | $-0.74 | $-0.74 | $-0.75 | $-0.90 | |
| EPS (Diluted) | $-0.43 | $-0.92 | $-1.12 | $-0.99 | $-0.98 | $-0.92 | $-0.91 | $-0.84 | $-0.87 | $-1.06 | $-0.84 | $-0.80 | $-0.74 | $-0.74 | $-0.75 | $-0.90 | |
| Shares (Basic) | 54,583,424 | 53,883,681 | 53,497,128 | -97,159,000 | 53,067,581 | 52,638,888 | 46,695,220 | 46,590,154 | 46,232,977 | -78,783,760 | 34,723,379 | 34,565,955 | 34,414,226 | -49,540,261 | 28,278,453 | 24,595,039 | |
| Shares (Diluted) | 54,583,424 | 53,883,681 | 53,497,128 | -97,159,000 | 53,067,581 | 52,638,888 | 46,695,220 | 46,590,154 | 46,232,977 | -78,783,760 | 34,723,379 | 34,565,955 | 34,414,226 | -49,540,261 | 28,278,453 | 24,595,039 | |
| EBITDA | $-23M | $-46M | $-59M | · | · | $-43M | $-46M | · | $-44M | · | $-33M | $-30M | $-29M | · | $-27M | $-26M |
Bilan 22
| Métrique | Tendance | Q1 2026 | Q3 2025 | Q1 2025 | Q4 2025 | Q1 2025 | Q3 2025 | Q2 2024 | Q3 2024 | Q1 2024 | Q4 2024 | Q3 2024 | Q2 2023 | Q1 2023 | Q4 2023 | Q3 2023 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $214M | $243M | $124M | $132M | · | $167M | $42M | · | $32M | $32M | $23M | $58M | $49M | $56M | $85M | $39M | |
| Receivables | $10M | $6M | $2M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Inventory | $4M | $458.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $8M | $8M | $12M | $20M | · | $7M | $5M | · | $7M | $7M | $6M | $5M | $8M | $6M | $9M | $9M | |
| Current Assets | $314M | $325M | $206M | $242M | · | $267M | $152M | · | $192M | $226M | $104M | $129M | $150M | $172M | $192M | $151M | |
| PP&E (Net) | $3M | $3M | $2M | $2M | · | $2M | $2M | · | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | |
| PP&E (Gross) | · | · | · | $7M | · | · | · | · | · | $6M | · | · | · | $6M | · | · | |
| Accum. Depreciation | · | · | $5M | $5M | · | · | · | · | · | $4M | · | · | · | $3M | · | · | |
| Other Non-current Assets | $2M | $2M | $2M | $2M | · | $1M | $662.0K | · | $605.0K | $567.0K | $397.0K | $337.0K | $106.0K | $106.0K | $197.0K | $197.0K | |
| Total Assets | $329M | $340M | $216M | $251M | · | $276M | $161M | · | $200M | $235M | $114M | $139M | $160M | $183M | $203M | $163M | |
| Accounts Payable | $8M | $8M | $6M | $5M | · | $6M | $5M | · | $11M | $9M | $3M | $5M | $5M | $5M | $2M | $3M | |
| Accrued Liabilities | $34M | $21M | $19M | $27M | · | $18M | $15M | · | $10M | $12M | $15M | $12M | $8M | $9M | $9M | $7M | |
| Current Liabilities | $61M | $45M | $38M | $45M | · | $26M | $22M | · | $22M | $23M | $19M | $18M | $14M | $15M | $12M | $11M | |
| Capital Leases | $10M | $9M | $4M | $4M | · | $4M | $5M | · | $5M | $6M | $6M | $7M | $7M | $7M | $7M | $8M | |
| Total Liabilities | $349M | $323M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Long-term Debt | $172M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $51.0K | $50.0K | $50.0K | $50.0K | · | $49.0K | $43.0K | · | $43.0K | $42.0K | $34.0K | $34.0K | $34.0K | $34.0K | $34.0K | $25.0K | |
| Retained Earnings | $-786M | $-739M | $-713M | $-653M | · | $-601M | $-552M | · | $-510M | $-470M | $-425M | $-396M | $-368M | $-343M | $-317M | $-295M | |
| AOCI | $-7M | $-7M | $-6M | $-5M | · | $-2M | $-3M | · | $-3M | $-3M | $-3M | $-3M | $-3M | $-3M | $-4M | $-5M | |
| Stockholders' Equity | $-20M | $17M | $41M | $95M | · | $145M | $134M | · | $173M | $207M | $89M | $114M | $139M | $161M | $184M | $144M | |
| Liabilities + Equity | $329M | $340M | $216M | $251M | · | $276M | $161M | · | $200M | $235M | $114M | $139M | $160M | $183M | $203M | $163M | |
| Shares Outstanding | 51,237,509 | 50,542,711 | 50,339,823 | 49,762,048 | · | 49,493,210 | 43,271,501 | · | 43,081,922 | 42,521,975 | 34,595,623 | 34,421,458 | 34,266,595 | 34,171,138 | 34,127,762 | 24,602,023 |
Flux de trésorerie 10
| Métrique | Tendance | Q1 2026 | Q3 2025 | Q1 2025 | Q4 2025 | Q1 2025 | Q3 2025 | Q2 2024 | Q3 2024 | Q1 2024 | Q4 2024 | Q3 2024 | Q2 2023 | Q1 2023 | Q4 2023 | Q3 2023 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $355.0K | $416.0K | $252.0K | $74.0K | $251.0K | $229.0K | $227.0K | $274.0K | $224.0K | $152.0K | $207.0K | $197.0K | $193.0K | $188.0K | $199.0K | $173.0K | |
| Stock-based Comp | $5M | · | · | · | $3M | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | $4M | · | $5M | · | · | · | · | · | $-1.0K | · | · | · | $-2M | · | · | · | |
| Operating Cash Flow | $-14M | $-47M | $-55M | $-26M | $-48M | $-33M | $-40M | $-45M | $-40M | $2M | $-28M | $-20M | $-27M | $-23M | $-9M | $-21M | |
| CapEx | $121.0K | $2M | $290.0K | $-1M | $288.0K | $24.0K | $108.0K | $45.0K | $21.0K | $-11.0K | $19.0K | $2.0K | $6.0K | $69.0K | $15.0K | $192.0K | |
| Investing Cash Flow | $-901.0K | $-66M | $21M | $71M | $-4M | $9M | $49M | $-104M | $37M | $-29M | $-7M | $29M | $20M | $-6M | $-3M | $20M | |
| Stock Issued | · | · | · | $0 | · | · | · | · | · | $0 | · | · | · | $0 | · | · | |
| Financing Cash Flow | $1M | $161M | $23M | $-5M | $2M | $152M | $295.0K | $153M | $3M | $-3M | $284.0K | $128.0K | $204.0K | $-33.0K | $58M | $168.0K | |
| Net Change in Cash | $-16M | $52M | $-7M | $39M | $-47M | $126M | $10M | $5M | $59.0K | $-31M | $-35M | $8M | $-7M | $-29M | $46M | $722.0K | |
| Free Cash Flow | $-15M | · | $-55M | · | · | · | · | · | $-40M | · | · | · | $-27M | · | · | · |
Rentabilité 7
| Métrique | Tendance | Q1 2026 | Q3 2025 | Q1 2025 | Q4 2025 | Q1 2025 | Q3 2025 | Q2 2024 | Q3 2024 | Q1 2024 | Q4 2024 | Q3 2024 | Q2 2023 | Q1 2023 | Q4 2023 | Q3 2023 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -336.1% | -4214.9% | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Margin | · | -361.2% | -4292.6% | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Pretax Margin | · | -345.4% | -4138.5% | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | · | -336.1% | -4196.9% | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| ROA | -8.6% | -16.1% | -28.9% | · | · | -24.9% | -28.2% | · | -22.4% | · | -18.3% | -18.3% | -14.8% | · | -9.9% | -10.9% | |
| ROE | -222.2% | -61.0% | -56.3% | · | · | -41.5% | -34.0% | · | -25.9% | · | -21.3% | -21.4% | -16.7% | · | -10.9% | -12.0% | |
| ROIC | 119.3% | -283.2% | -150.0% | · | · | -32.4% | · | · | · | · | · | · | · | · | · | · |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q1 2026 | Q3 2025 | Q1 2025 | Q4 2025 | Q1 2025 | Q3 2025 | Q2 2024 | Q3 2024 | Q1 2024 | Q4 2024 | Q3 2024 | Q2 2023 | Q1 2023 | Q4 2023 | Q3 2023 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.2 | 7.2 | 5.4 | · | · | 10.4 | 6.9 | · | 8.6 | · | 5.4 | 7.2 | 10.6 | · | 16.6 | 13.4 | |
| Quick Ratio | 3.7 | 5.5 | 3.3 | · | · | 6.5 | 1.9 | · | 1.4 | · | 1.2 | 3.2 | 3.5 | · | 7.3 | 3.4 |
Efficacité 3
| Métrique | Tendance | Q1 2026 | Q3 2025 | Q1 2025 | Q4 2025 | Q1 2025 | Q3 2025 | Q2 2024 | Q3 2024 | Q1 2024 | Q4 2024 | Q3 2024 | Q2 2023 | Q1 2023 | Q4 2023 | Q3 2023 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Inventory Turnover | 1.5 | 5.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Receivables Turnover | · | 4.7 | 1.5 | · | · | · | · | · | · | · | · | · | · | · | · | · |
Valorisation (TTM) 10
| Métrique | Tendance | Q1 2026 | Q3 2025 | Q1 2025 | Q4 2025 | Q1 2025 | Q3 2025 | Q2 2024 | Q3 2024 | Q1 2024 | Q4 2024 | Q3 2024 | Q2 2023 | Q1 2023 | Q4 2023 | Q3 2023 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | · | · | · | $13M | $13M | $13M | · | $13M | $13M | |
| Net Income TTM | $-191M | · | · | · | · | · | · | · | · | · | $-103M | $-97M | $-92M | · | $-89M | $-87M | |
| Market Cap | $1.03B | $616M | $686M | · | · | $441M | $444M | · | $626M | · | $546M | $292M | $346M | · | $272M | $125M | |
| P/E | -5.8 | -3.1 | -3.6 | · | · | · | -3.0 | · | -4.5 | · | -5.0 | -2.7 | -3.0 | · | -2.3 | -1.4 | |
| P/S | · | · | · | · | · | · | · | · | · | · | 43.0 | 23.0 | 27.3 | · | 21.4 | 9.8 | |
| P/B | -52.5 | 36.2 | 16.8 | · | · | 3.0 | 3.3 | · | 3.6 | · | 6.2 | 2.6 | 2.5 | · | 1.5 | 0.9 | |
| P / Tangible Book | · | 36.2 | 16.8 | · | · | 3.0 | 3.3 | · | 3.6 | · | 6.2 | 2.6 | 2.5 | · | 1.5 | 0.9 | |
| P / Cash Flow | -71.4 | · | -12.6 | · | · | · | · | · | -15.6 | · | · | · | -12.9 | · | · | · | |
| P / FCF | -70.8 | · | -12.5 | · | · | · | · | · | -15.6 | · | · | · | -12.9 | · | · | · | |
| Earnings Yield | -17.1% | -31.8% | -27.8% | · | · | · | -33.7% | · | -22.4% | · | -19.9% | -37.6% | -33.0% | · | -44.1% | -70.2% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2025-04-30 | 2024-12-31 | 2024-04-30 | 2023-04-30 | |
|---|---|---|---|---|---|
| Revenu | — | — | — | $50M | — |
| Résultat net | — | $-183M | — | $-127M | $-93M |
| BPA dilué | — | $-3.69 | — | $-3.44 | $-3.33 |
Bilan
| 2025-12-31 | 2025-04-30 | 2024-12-31 | 2024-04-30 | 2023-04-30 | |
|---|---|---|---|---|---|
| Ratio de liquidité | — | 5.4 | — | 9.9 | 11.5 |
| Ratio de liquidité réduite | — | 2.9 | — | 1.4 | 3.7 |
Flux de trésorerie
| 2025-12-31 | 2025-04-30 | 2024-12-31 | 2024-04-30 | 2023-04-30 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | — | $-153M | — | $-89M | $-76M |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.